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 Implication for health policy/practice/research/medical edu-
cation:
Hepatitis B vaccination plays an important role in HBV 
prevention. Special groups of patients, such as patients with 
celiac  disease  respond  differently  to  HBV  vaccination.  We 
highly recommend Gastroenterologists, infectious specialists, 
pediatricians, immunologists and virologists to study this 
article.
Vaccination is an efficient and reliable means of pro-
tection against common hepatitis B virus (HBV) infec-
tions (1). Between 90% and 95% of the adult population 
responds to HBV vaccination (2, 3), and 4–10 % of vaccine 
recipients fail to respond to standard immunization (1, 
4, 5). The ability to respond to recombinant HBV vaccine 
is associated with immunogenetically condition because 
of multiple candidate genes (6, 7). Some specific HLA hap-
lotypes are considered to be the most important genetic 
markers for non-responders, who are found to carry spe-
cific haplotypes such as B8, DR3, and DQ2 (6, 7). Since HLA 
genotypes play an important role in unresponsiveness 
to the HBV vaccine, celiac disease (CD) may be associated 
with this unresponsiveness (8). CD is a common autoim-
mune disorder, which has a particularly strong associa-
tion with the presence of HLA-DQ2 in 90–95% of the pa-
tients (9-12).
In an issue of Hepatitis Monthly (13), Ertekin et al. 
reported the results of their study on 52 children with 
CD and 20 age- and sex-matched healthy children who 
received HBV vaccination as per an immunization 
schedule. The proportion of children in the CD group 
who failed to respond to HBV vaccination (32 of 52) was 
significantly higher than the proportion of control 
individuals  who  did  not  (18  of  20;  61.5%  vs.  90%;  P < 
0.05).  Ertekin  et al. concluded that unresponsiveness 
to  hepatitis  B  vaccination  was  found  in  a  higher 
percentage in children with CD than the control group. 
They concluded that response to the HBV vaccine in 
children with CD should be investigated and a different 
immunization schedule should be developed for them. 
They  also  suggested  that  compliance  with  a  gluten-
free diet may improve the immune response of celiac 
children to the HBV vaccine. Most studies on this topic 
have demonstrated that the number of children with CD 
who failed to respond to the HBV vaccine is significantly 
greater than that of healthy children (4, 5, 8, 14).
In a similar study on an adult cohort, Noh et al. found 
that of 23 adults with CD who had completed a full course 
of HBV vaccination, 19 tested positive for HBsAb and 13 
did not show long-term immunity (15).
This association of HLA with non-responsiveness to 
HBV  vaccination  was  further  confirmed  in  a  study  by 
Stachowski et al., where 34 out of 153 patients with end-
stage renal disease were non-responsive to a recombinant 
HBV vaccine and HLA-DQ2 was found almost exclusively Hepat Mon. 2011;11(8):597-598
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in the non-responder group (7).
Longer intervals between vaccination and antibody 
testing might be one of the reasons for significantly low 
protective post-vaccination HBV antibody titers even 
in CD patients who comply with dietary guidelines (8, 
14). Therefore, revaccination is recommended when the 
patients are following a controlled gluten-free diet.
This  study  was  not  designed  to  determine  the 
presence of HLA-DQ2 and HLA-DQ8 in both the groups. 
Therefore, future studies evaluating the HLA haplotypes 
in CD and control groups should aim to characterize the 
role of HLA typing in the response to HBV vaccination.
As in the case of other conditions and as indicated by 
the strong evidence for the protective role of GFD, early 
diagnosis of CD may obviously increase the percentage 
of  patients  responding  to  the  HBV  vaccine.  Moreover, 
beginning  with  a  short  duration,  strict,  gluten-free 
diet seems to play a positive role in the development of 
antibody memory. Given the high prevalence of CD in the 
general population and a lack of response to HBV vaccine 
in untreated patients, we think that non-responsiveness 
to HBV vaccine necessitates routine assessment in 
patients  with  CD.  Non-responsiveness  to  HBV  vaccine 
may be a possible sign of undiagnosed CD or may suggest 
noncompliance with gluten-free diet.
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